SCHEDULE: Goldman Sachs Discloses 8.9% Stake in Fortrea
Beneficial Ownership Report
The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 8.9% in Fortrea Holdings Inc.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC jointly reported beneficial ownership of 8,031,366.47 shares of Fortrea Holdings Inc. Common Stock.
- This ownership represents 8.9% of Fortrea Holdings Inc.'s outstanding common stock.
- The reporting entities hold shared voting power over 8,028,366.47 shares and shared dispositive power over 8,031,366.47 shares.
- The filing was made pursuant to Rule 13d-1(b), indicating the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- Fortrea Holdings Inc.'s principal executive offices are located at 8 Moore Dr, Durham, X1, 27709.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive as a significant institutional investment can be seen as a vote of confidence, but the filing itself is purely factual and does not contain performance-related information.
Positives
- A significant stake by a major financial institution like Goldman Sachs can signal confidence in Fortrea Holdings Inc.'s long-term prospects.
- The filing indicates that Goldman Sachs holds the shares in the ordinary course of business, suggesting a strategic investment rather than an activist position.
Risks
- The filing itself does not detail specific risks related to Fortrea Holdings Inc.'s operations or financial health, as it is a beneficial ownership report.
Future Outlook
The filing does not provide forward-looking statements or guidance regarding Fortrea Holdings Inc.'s future performance or strategic direction, as it is a disclosure of beneficial ownership.
Industry Context
This filing indicates a significant investment by a major financial institution in Fortrea Holdings Inc., a company operating in the clinical research or healthcare services sector. Such investments can reflect broader institutional interest in the industry's growth prospects or specific company fundamentals, though the filing itself does not elaborate on the rationale.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Goldman Sachs could positively influence investor perception and potentially the stock price, signaling institutional confidence.
- Company Management: Awareness of a major institutional holder may influence strategic decisions, though Goldman Sachs states its holding is for ordinary course of business.
Key Dates
| Date | Description |
|---|---|
| 2024-07-29 | Previous Power of Attorney granted by The Goldman Sachs Group, Inc. was superseded. |
| 2024-10-01 | Previous Power of Attorney granted by Goldman Sachs & Co. LLC was superseded. |
| 2025-06-30 | Date of event which required the filing of this statement (reporting period end date). |
| 2025-07-16 | Date of execution for the new Power of Attorney by Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. |
| 2025-07-17 | Date of signature for the Schedule 13G filing. |
| 2026-07-16 | Expiration date of the current Power of Attorney, unless revoked earlier. |
Keywords
Fortrea Holdings Inc., Goldman Sachs, Beneficial Ownership, SEC Filing, Common Stock, Institutional Investment, Healthcare, Clinical Research
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.